JP2002506437A - 癌の新規な検出および治療方法 - Google Patents
癌の新規な検出および治療方法Info
- Publication number
- JP2002506437A JP2002506437A JP50316799A JP50316799A JP2002506437A JP 2002506437 A JP2002506437 A JP 2002506437A JP 50316799 A JP50316799 A JP 50316799A JP 50316799 A JP50316799 A JP 50316799A JP 2002506437 A JP2002506437 A JP 2002506437A
- Authority
- JP
- Japan
- Prior art keywords
- esbpii
- endometrial
- cancer
- protein
- endometriosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/16—Phosphorus containing
- Y10T436/166666—Phosphorus containing of inorganic phosphorus compound in body fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.治療上有効量のESBPIIアンタゴニストを患者に投与することを含む、 子宮内膜癌、乳癌、子宮内膜症または子宮内膜線維症の治療方法。 2.細胞、組織および体液中の異常に高いESBPIIポリペプチドのレベルを 分析することを含む、子宮内膜癌、乳癌、子宮内膜症または子宮内膜線維症の診 断方法。 3.診断方法がELISAを含むものである請求項2の方法。 4.診断方法が免疫組織化学的方法である請求項2の方法。 5.細胞、組織および体液中の異常に高いまたは低いESBPII転写レベルを 分析することを含む、子宮内膜癌、乳癌、子宮内膜症または子宮内膜線維症の診 断方法。 6.診断方法がノーザンブロット分析を含むものである請求項5の方法。 7.診断方法がin situハイブリダイゼーションを含むものである請求項5の 方法。 8.診断方法がRT−PCRを含むものである請求項5の方法。 9.診断方法がグリッディングを含むものである請求項5の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4901597P | 1997-06-09 | 1997-06-09 | |
US60/049,015 | 1997-06-09 | ||
PCT/US1998/012053 WO1998056248A1 (en) | 1997-06-09 | 1998-06-09 | A novel method of detecting and treating cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002506437A true JP2002506437A (ja) | 2002-02-26 |
JP2002506437A5 JP2002506437A5 (ja) | 2005-12-22 |
Family
ID=21957635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50316799A Ceased JP2002506437A (ja) | 1997-06-09 | 1998-06-09 | 癌の新規な検出および治療方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US6667291B2 (ja) |
EP (1) | EP0987943B1 (ja) |
JP (1) | JP2002506437A (ja) |
CA (1) | CA2289471A1 (ja) |
DE (1) | DE69830169T2 (ja) |
WO (1) | WO1998056248A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174992B1 (en) | 1997-03-21 | 2001-01-16 | Human Genome Sciences, Inc. | Human endometrial specific steroid-binding factor I, II and III |
US7014996B1 (en) | 1998-10-02 | 2006-03-21 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
JP2002526752A (ja) * | 1998-10-05 | 2002-08-20 | ダイアデクスアス・インコーポレーテッド | 婦人科がんおよび前立腺がんの診断、モニタリング、病期分類および治療の新規方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5696092A (en) | 1995-03-07 | 1997-12-09 | George Washington University | Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers |
US5668267A (en) | 1995-05-31 | 1997-09-16 | Washington University | Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein |
WO1997034997A1 (en) * | 1996-03-21 | 1997-09-25 | Human Genome Sciences, Inc. | Human endometrial specific steroid-binding factor i, ii and iii |
WO1998007857A1 (en) | 1996-08-19 | 1998-02-26 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the breast |
AU7180198A (en) * | 1996-11-12 | 1998-06-03 | Incyte Pharmaceuticals, Inc. | Human breast tumor-specific proteins |
-
1998
- 1998-06-09 EP EP98926527A patent/EP0987943B1/en not_active Expired - Lifetime
- 1998-06-09 US US09/423,186 patent/US6667291B2/en not_active Expired - Fee Related
- 1998-06-09 DE DE69830169T patent/DE69830169T2/de not_active Expired - Fee Related
- 1998-06-09 JP JP50316799A patent/JP2002506437A/ja not_active Ceased
- 1998-06-09 WO PCT/US1998/012053 patent/WO1998056248A1/en active IP Right Grant
- 1998-06-09 CA CA002289471A patent/CA2289471A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69830169T2 (de) | 2006-02-16 |
US20030175279A1 (en) | 2003-09-18 |
WO1998056248A1 (en) | 1998-12-17 |
US6667291B2 (en) | 2003-12-23 |
CA2289471A1 (en) | 1998-12-17 |
DE69830169D1 (de) | 2005-06-16 |
EP0987943B1 (en) | 2005-05-11 |
EP0987943A4 (en) | 2001-03-14 |
EP0987943A1 (en) | 2000-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100331363B1 (ko) | 사이클린복합체재배열및그것과관련된용도 | |
JP3294575B2 (ja) | Igf−1レセプターと相互作用するタンパク質、それをコードする遺伝子及びそれらの使用 | |
JP2006201187A (ja) | 前立腺ガンの免疫診断のための化合物およびそれらの使用方法 | |
US20040053262A1 (en) | Supressor gene | |
US6228596B1 (en) | Method of detecting and monitoring endometrial and uterine cancers | |
US20020068307A1 (en) | Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer | |
EP0887081B1 (en) | Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy | |
US5942402A (en) | Method of detecting and treating cancer | |
AU2001256353A1 (en) | Cancer diagnosis and assays for screening anti-cancer agents | |
JPH11123086A (ja) | セリン−トレオニンプロテインキナーゼ(h−sgk2) | |
RU2307666C2 (ru) | Полинуклеотид, модулирующий пролиферацию раковых клеток (варианты), полипептид, моноклональное антитело, вектор экспрессии, клетка-хозяин, лекарственное средство для лечения пролиферативного заболевания, фармацевтическая композиция, применение полипептида для получения лекарственного средства | |
US5747264A (en) | Method of diagnosing and monitoring prostate cancer | |
US6667291B2 (en) | Method of detecting and treating cancer | |
US20040072268A1 (en) | Methods for regulating BRCA1-BRCA2-containing complex activity | |
US7883896B2 (en) | Marker molecules associated with lung tumors | |
US6379951B1 (en) | Compounds for immunotherapy of breast cancer and methods for their use | |
JP2001500847A (ja) | 癌の検出および処置の新規方法 | |
JP2005000056A (ja) | ホルモン依存性癌疾患マーカー及びその利用 | |
JP3524536B2 (ja) | 癌の診断、モニタリング、ステージング、イメージングおよび処置のための新規方法 | |
JP3524537B2 (ja) | 癌の診断、モニタリング、ステージング、イメージングおよび処置のための新規方法 | |
EP0837127A2 (en) | Hereditary multiple exostose gene, Ext2 | |
JP2002223778A (ja) | 慢性腎不全の標的およびマーカーであるcrfg−1 | |
WO1999015544A1 (en) | NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE brx GENE AND GENE PRODUCT, AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050609 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050609 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080729 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20081224 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090317 |